BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19851777)

  • 1. Capparis spinosa protects against oxidative stress in systemic sclerosis dermal fibroblasts.
    Cao YL; Li X; Zheng M
    Arch Dermatol Res; 2010 Jul; 302(5):349-55. PubMed ID: 19851777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate.
    Dooley A; Shi-Wen X; Aden N; Tranah T; Desai N; Denton CP; Abraham DJ; Bruckdorfer R
    Rheumatology (Oxford); 2010 Nov; 49(11):2024-36. PubMed ID: 20627968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Capparis spinosa on fibroblast proliferation and type I collagen production in progressive systemic sclerosis].
    Cao YL; Li X; Zheng M
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):560-3. PubMed ID: 18536384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts.
    Santiago B; Galindo M; Rivero M; Pablos JL
    Arthritis Rheum; 2001 Jul; 44(7):1667-76. PubMed ID: 11465719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
    Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
    Distler JH; Jüngel A; Pileckyte M; Zwerina J; Michel BA; Gay RE; Kowal-Bielecka O; Matucci-Cerinic M; Schett G; Marti HH; Gay S; Distler O
    Arthritis Rheum; 2007 Dec; 56(12):4203-15. PubMed ID: 18050252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocoa flavonoids up-regulate antioxidant enzyme activity via the ERK1/2 pathway to protect against oxidative stress-induced apoptosis in HepG2 cells.
    Martín MA; Serrano AB; Ramos S; Pulido MI; Bravo L; Goya L
    J Nutr Biochem; 2010 Mar; 21(3):196-205. PubMed ID: 19195869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate-dependent ERK activation contributes to the overexpression of fibrotic proteins and enhanced contraction by scleroderma fibroblasts.
    Chen Y; Leask A; Abraham DJ; Pala D; Shiwen X; Khan K; Liu S; Carter DE; Wilcox-Adelman S; Goetinck P; Denton CP; Black CM; Pitsillides AA; Sarraf CE; Eastwood M
    Arthritis Rheum; 2008 Feb; 58(2):577-85. PubMed ID: 18240216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway.
    Sambo P; Baroni SS; Luchetti M; Paroncini P; Dusi S; Orlandini G; Gabrielli A
    Arthritis Rheum; 2001 Nov; 44(11):2653-64. PubMed ID: 11710721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
    Hasegawa M; Matsushita Y; Horikawa M; Higashi K; Tomigahara Y; Kaneko H; Shirasaki F; Fujimoto M; Takehara K; Sato S
    Arthritis Rheum; 2009 Nov; 60(11):3465-75. PubMed ID: 19877032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis.
    Kubo M; Ihn H; Yamane K; Tamaki K
    J Rheumatol; 2002 Dec; 29(12):2558-64. PubMed ID: 12465152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Green tea extract protects human skin fibroblasts from reactive oxygen species induced necrosis.
    Silverberg JI; Jagdeo J; Patel M; Siegel D; Brody N
    J Drugs Dermatol; 2011 Oct; 10(10):1096-101. PubMed ID: 21968658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.
    Jelaska A; Korn JH
    Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhapontigenin from Rheum undulatum protects against oxidative-stress-induced cell damage through antioxidant activity.
    Zhang R; Kang KA; Piao MJ; Lee KH; Jang HS; Park MJ; Kim BJ; Kim JS; Kim YS; Ryu SY; Hyun JW
    J Toxicol Environ Health A; 2007 Jul; 70(13):1155-66. PubMed ID: 17558811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end-products activate extracellular signal-regulated kinase via the oxidative stress-EGF receptor pathway in renal fibroblasts.
    Chen SC; Guh JY; Hwang CC; Chiou SJ; Lin TD; Ko YM; Huang JS; Yang YL; Chuang LY
    J Cell Biochem; 2010 Jan; 109(1):38-48. PubMed ID: 19885844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
    Wang Y; Fan PS; Kahaleh B
    Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis.
    Servettaz A; Guilpain P; Goulvestre C; Chéreau C; Hercend C; Nicco C; Guillevin L; Weill B; Mouthon L; Batteux F
    Ann Rheum Dis; 2007 Sep; 66(9):1202-9. PubMed ID: 17363403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts.
    Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
    Arthritis Rheum; 2005 Sep; 52(9):2897-905. PubMed ID: 16142753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.